The difficulty defining "benefit" of new antineoplastic strategies.
作者信息
Markman M
出版信息
J Cancer Res Clin Oncol. 1994;120(10):569-70. doi: 10.1007/BF01212809.
Abstract
摘要
相似文献
1
The difficulty defining "benefit" of new antineoplastic strategies.定义新型抗肿瘤策略“获益”的困难。
J Cancer Res Clin Oncol. 1994;120(10):569-70. doi: 10.1007/BF01212809.
2
Overall survival: patient outcome, therapeutic objective, clinical trial end point, or public health measure?总生存期：患者预后、治疗目标、临床试验终点还是公共卫生指标？
J Clin Oncol. 2012 May 20;30(15):1750-4. doi: 10.1200/JCO.2011.38.6359. Epub 2012 Mar 5.
3
"Clinical benefit" following treatment with antineoplastic drugs: what does it mean and how should we measure it?
Curr Oncol Rep. 1999 Sep;1(1):1-2. doi: 10.1007/s11912-999-0001-y.
4
Epidermal growth factor receptor (EGFR) inhibitors for metastatic colorectal cancer.用于转移性结直肠癌的表皮生长因子受体（EGFR）抑制剂
Cochrane Database Syst Rev. 2017 Jun 27;6(6):CD007047. doi: 10.1002/14651858.CD007047.pub2.
5
Addition of taxane to induction therapy in head and neck malignancies: a systematic review and meta-analysis of randomized controlled trials.在头颈部恶性肿瘤诱导治疗中添加紫杉烷：一项随机对照试验的系统评价和荟萃分析。
Chemotherapy. 2013;59(6):435-40. doi: 10.1159/000360690. Epub 2014 Jul 23.
6
Positron emission tomography-adapted therapy for first-line treatment in individuals with Hodgkin lymphoma.正电子发射断层扫描适配疗法用于霍奇金淋巴瘤患者的一线治疗
Cochrane Database Syst Rev. 2015 Jan 9;1(1):CD010533. doi: 10.1002/14651858.CD010533.pub2.
7
Ganoderma lucidum (Reishi mushroom) for cancer treatment.灵芝用于癌症治疗。
Cochrane Database Syst Rev. 2012 Jun 13(6):CD007731. doi: 10.1002/14651858.CD007731.pub2.
8
Ganoderma lucidum (Reishi mushroom) for cancer treatment.灵芝用于癌症治疗。
Cochrane Database Syst Rev. 2016 Apr 5;4(4):CD007731. doi: 10.1002/14651858.CD007731.pub3.
9
Evaluation of Pancreatic Cancer Clinical Trials and Benchmarks for Clinically Meaningful Future Trials: A Systematic Review.评估胰腺癌临床试验和临床有意义的未来试验的基准：系统评价。
JAMA Oncol. 2016 Sep 1;2(9):1209-16. doi: 10.1001/jamaoncol.2016.0585.
10
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
本文引用的文献
1
2
An argument in support of cost-effectiveness analysis in oncology.
J Clin Oncol. 1988 Jun;6(6):937-9. doi: 10.1200/JCO.1988.6.6.937.
3
Chemotherapy can prolong survival in patients with advanced non-small-cell lung cancer--report of a Canadian multicenter randomized trial.化疗可延长晚期非小细胞肺癌患者的生存期——一项加拿大多中心随机试验报告。
J Clin Oncol. 1988 Apr;6(4):633-41. doi: 10.1200/JCO.1988.6.4.633.
4
Supportive care versus supportive care and combination chemotherapy in metastatic non-small cell lung cancer. Does chemotherapy make a difference?转移性非小细胞肺癌中支持性治疗与支持性治疗联合化疗的比较。化疗有作用吗？
Cancer. 1989 Apr 1;63(7):1271-8. doi: 10.1002/1097-0142(19890401)63:7<1271::aid-cncr2820630707>3.0.co;2-6.
5
High-dose chemotherapy with reinfusion of purged autologous bone marrow following dose-intense induction as initial therapy for metastatic breast cancer.大剂量化疗联合剂量密集诱导后回输净化的自体骨髓作为转移性乳腺癌的初始治疗。
J Natl Cancer Inst. 1991 Jul 3;83(13):920-6. doi: 10.1093/jnci/83.13.920.
6
A randomized trial of alternating chemotherapy versus best supportive care in advanced non-small-cell lung cancer.
J Clin Oncol. 1991 Aug;9(8):1453-61. doi: 10.1200/JCO.1991.9.8.1453.
7
Therapeutic alternatives in clinical stage I nonseminomatous disease.临床I期非精原细胞瘤疾病的治疗选择
Semin Oncol. 1992 Apr;19(2):190-6.
8
High-dose consolidation therapy with autologous stem-cell rescue in stage IV breast cancer: follow-up report.IV期乳腺癌高剂量巩固治疗联合自体干细胞解救：随访报告
J Clin Oncol. 1992 Nov;10(11):1743-7. doi: 10.1200/JCO.1992.10.11.1743.
9
High-dose chemotherapy with autologous bone marrow transplantation for the treatment of metastatic breast cancer.大剂量化疗联合自体骨髓移植治疗转移性乳腺癌。
J Clin Oncol. 1992 Apr;10(4):657-70. doi: 10.1200/JCO.1992.10.4.657.
Zotero 插件